Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Improved Detection of Visual Field Progression Using a Spatiotemporal Boundary Detection Method.

Berchuck SI, Mwanza JC, Tanna AP, Budenz DL, Warren JL.

Sci Rep. 2019 Mar 15;9(1):4642. doi: 10.1038/s41598-018-37127-z.

2.

High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Kang A, Antonelou M, Wong NL, Tanna A, Arulkumaran N, Tam FWK, Pusey CD.

J Rheumatol. 2019 Mar;46(3):285-293. doi: 10.3899/jrheum.170896. Epub 2018 Nov 1.

PMID:
30385704
3.

Geographic and Provider Variations in Ocular Hypotensive Medication Claims Among Medicare Part D Enrollees.

Janetos TM, French DD, Beaumont JL, Tanna AP.

J Glaucoma. 2019 Feb;28(2):e29-e33. doi: 10.1097/IJG.0000000000001114.

PMID:
30358645
4.

Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension.

Tanna AP, Johnson M.

Ophthalmology. 2018 Nov;125(11):1741-1756. doi: 10.1016/j.ophtha.2018.04.040. Epub 2018 Jul 12. Review.

PMID:
30007591
5.

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis.

McAdoo SP, Medjeral-Thomas N, Gopaluni S, Tanna A, Mansfield N, Galliford J, Griffith M, Levy J, Cairns TD, Jayne D, Salama AD, Pusey CD.

Nephrol Dial Transplant. 2018 May 1;33(5):899. doi: 10.1093/ndt/gfy075. No abstract available.

PMID:
29617842
6.

Increased Prevalence of Thyroid Disease in Patients with Antineutrophil Cytoplasmic Antibodies-associated Vasculitis.

Prendecki M, Martin L, Tanna A, Antonelou M, Pusey CD.

J Rheumatol. 2018 May;45(5):686-689. doi: 10.3899/jrheum.170661. Epub 2018 Mar 15.

PMID:
29545453
7.

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis.

McAdoo SP, Medjeral-Thomas N, Gopaluni S, Tanna A, Mansfield N, Galliford J, Griffith M, Levy J, Cairns TD, Jayne D, Salama AD, Pusey CD.

Nephrol Dial Transplant. 2019 Jan 1;34(1):63-73. doi: 10.1093/ndt/gfx378.

8.

The Challenge of Detecting Glaucoma Progression.

Tanna AP.

Ophthalmology. 2017 Dec;124(12S):S49-S50. doi: 10.1016/j.ophtha.2017.10.022. No abstract available.

PMID:
29157361
9.

PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical Trial.

Jampol LM, Odia I, Glassman AR, Baker CW, Bhorade AM, Han DP, Jaffe GJ, Melia M, Bressler NM, Tanna AP; Diabetic Retinopathy Clinical Research Network.

Retina. 2019 Jan;39(1):69-78. doi: 10.1097/IAE.0000000000001909.

PMID:
29135802
10.

Peripapillary retinal splitting visualized on OCT in glaucoma and glaucoma suspect patients.

Grewal DS, Merlau DJ, Giri P, Munk MR, Fawzi AA, Jampol LM, Tanna AP.

PLoS One. 2017 Aug 23;12(8):e0182816. doi: 10.1371/journal.pone.0182816. eCollection 2017.

11.

The effect of cutaneous prostaglandin application on nail growth, nail brittleness, and intraocular pressure.

Palmer DJ, Scheman A, Tanna AP, Bueno A.

J Cosmet Dermatol. 2018 Apr;17(2):263-267. doi: 10.1111/jocd.12372. Epub 2017 Jul 6.

PMID:
28681570
12.

Label Free Detection of Sensitive Mid-Infrared Biomarkers of Glomerulonephritis in Urine Using Fourier Transform Infrared Spectroscopy.

Yu MC, Rich P, Foreman L, Smith J, Yu MS, Tanna A, Dibbur V, Unwin R, Tam FWK.

Sci Rep. 2017 Jul 4;7(1):4601. doi: 10.1038/s41598-017-04774-7.

13.

A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification.

Hassan U, Ghonge T, Reddy B Jr, Patel M, Rappleye M, Taneja I, Tanna A, Healey R, Manusry N, Price Z, Jensen T, Berger J, Hasnain A, Flaugher E, Liu S, Davis B, Kumar J, White K, Bashir R.

Nat Commun. 2017 Jul 3;8:15949. doi: 10.1038/ncomms15949.

14.

Growing Evidence of the Importance of the Macula in Glaucoma.

Tanna AP.

JAMA Ophthalmol. 2017 Jul 1;135(7):747-748. doi: 10.1001/jamaophthalmol.2017.1379. No abstract available.

PMID:
28542686
15.

Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.

McAdoo SP, Tanna A, Hrušková Z, Holm L, Weiner M, Arulkumaran N, Kang A, Satrapová V, Levy J, Ohlsson S, Tesar V, Segelmark M, Pusey CD.

Kidney Int. 2017 Sep;92(3):693-702. doi: 10.1016/j.kint.2017.03.014. Epub 2017 May 12.

16.

Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids.

Prendecki M, Tanna A, Salama AD, Tam FW, Cairns T, Taube D, Cook HT, Ashby D, Duncan ND, Pusey CD.

Clin Kidney J. 2017 Apr;10(2):233-239. doi: 10.1093/ckj/sfw116. Epub 2016 Dec 24.

17.

The Histopathological Classification of ANCA-associated Glomerulonephritis Comes of Age.

Tanna A, Pusey CD.

J Rheumatol. 2017 Mar;44(3):265-267. doi: 10.3899/jrheum.170006. No abstract available.

18.

Nickel Catalyzed Copolymerization of Ethylene and Alkyl Acrylates.

Xin BS, Sato N, Tanna A, Oishi Y, Konishi Y, Shimizu F.

J Am Chem Soc. 2017 Mar 15;139(10):3611-3614. doi: 10.1021/jacs.6b13051. Epub 2017 Mar 1.

PMID:
28218852
19.

Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial.

Tanna AP, Rademaker AW, de Moraes CG, Godfrey DG, Sarkisian SR Jr, Vold SD, Ritch R.

BMC Ophthalmol. 2016 Dec 29;16(1):217. doi: 10.1186/s12886-016-0393-z.

20.

A Statistical Model to Analyze Clinician Expert Consensus on Glaucoma Progression using Spatially Correlated Visual Field Data.

Warren JL, Mwanza JC, Tanna AP, Budenz DL.

Transl Vis Sci Technol. 2016 Aug 31;5(4):14. eCollection 2016 Aug.

21.

Chronic postoperative endophthalmitis after cataract surgery secondary to vancomycin-resistant Ochrobactrum anthropi: case report and literature review.

Kanjee R, Koreishi AF, Tanna AP, Goldstein DA.

J Ophthalmic Inflamm Infect. 2016 Dec;6(1):25. doi: 10.1186/s12348-016-0094-z. Epub 2016 Jul 15.

22.

Inter-Rater Agreement in the Assessment of Video Recordings of Eye Drop Instillation by Glaucoma Patients.

Park MS, Patel MM, Sarezky D, Rojas C, Choo C, Choi M, Liu D, Rademaker AW, Tanna AP.

PLoS One. 2016 Jan 5;11(1):e0145764. doi: 10.1371/journal.pone.0145764. eCollection 2016.

23.

Nailfold Capillary Abnormalities in Primary Open-Angle Glaucoma: A Multisite Study.

Pasquale LR, Hanyuda A, Ren A, Giovingo M, Greenstein SH, Cousins C, Patrianakos T, Tanna AP, Wanderling C, Norkett W, Wiggs JL, Green K, Kang JH, Knepper PA.

Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7021-8. doi: 10.1167/iovs.15-17860.

24.

Outcome and treatment of elderly patients with ANCA-associated vasculitis.

Weiner M, Goh SM, Mohammad AJ, Hruskova Z, Tanna A, Bruchfeld A, Selga D, Chocova Z, Westman K, Eriksson P, Pusey CD, Tesar V, Salama AD, Segelmark M.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1128-35. doi: 10.2215/CJN.00480115. Epub 2015 Jun 22.

25.
26.

Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease.

Joshi L, Tanna A, McAdoo SP, Medjeral-Thomas N, Taylor SR, Sandhu G, Tarzi RM, Pusey CD, Lightman S.

Ophthalmology. 2015 Jun;122(6):1262-8. doi: 10.1016/j.ophtha.2015.01.016. Epub 2015 Mar 4.

PMID:
25745876
27.

A Novel Computerized Portable Pupillometer Detects and Quantifies Relative Afferent Pupillary Defects.

Cohen LM, Rosenberg MA, Tanna AP, Volpe NJ.

Curr Eye Res. 2015;40(11):1120-7. doi: 10.3109/02713683.2014.980007. Epub 2015 Feb 6.

PMID:
25658805
28.

Clinical trials. Rituximab for maintenance of remission in AAV.

Tanna A, Pusey C.

Nat Rev Nephrol. 2015 Mar;11(3):131-2. doi: 10.1038/nrneph.2014.254. Epub 2015 Jan 20.

PMID:
25599619
29.

Medical therapy for glaucoma: what to add after a prostaglandin analogs?

Tanna AP, Lin AB.

Curr Opin Ophthalmol. 2015 Mar;26(2):116-20. doi: 10.1097/ICU.0000000000000134. Review.

PMID:
25594765
30.

Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series.

McAdoo SP, Tanna A, Randone O, Tam FW, Tarzi RM, Levy JB, Griffith M, Lightstone L, Cook HT, Cairns T, Pusey CD.

Rheumatology (Oxford). 2015 Jun;54(6):1025-32. doi: 10.1093/rheumatology/keu445. Epub 2014 Nov 26.

31.

Bilateral angle closure following use of a weight loss combination agent containing topiramate.

Grewal DS, Goldstein DA, Khatana AK, Tanna AP.

J Glaucoma. 2015 Jun-Jul;24(5):e132-6. doi: 10.1097/IJG.0000000000000157.

PMID:
25304279
32.

Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors.

Tanna A, Guarino L, Tam FW, Rodriquez-Cubillo B, Levy JB, Cairns TD, Griffith M, Tarzi RM, Caplin B, Salama AD, Cook T, Pusey CD.

Nephrol Dial Transplant. 2015 Jul;30(7):1185-92. doi: 10.1093/ndt/gfu237. Epub 2014 Jul 12.

33.

Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis.

Todd SK, Pepper RJ, Draibe J, Tanna A, Pusey CD, Mauri C, Salama AD.

Rheumatology (Oxford). 2014 Sep;53(9):1693-703. doi: 10.1093/rheumatology/keu136. Epub 2014 Apr 11.

34.

Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN.

McAdoo SP, Reynolds J, Bhangal G, Smith J, McDaid JP, Tanna A, Jackson WD, Masuda ES, Cook HT, Pusey CD, Tam FW.

J Am Soc Nephrol. 2014 Oct;25(10):2291-302. doi: 10.1681/ASN.2013090978. Epub 2014 Apr 3.

35.

Associations of Injurious Falls and Self-Reported Incapacities: Analysis of the National Health Interview Survey.

French DD, Margo CE, Tanna AP, Volpe NJ, Rubenstein LZ.

J Patient Saf. 2016 Sep;12(3):148-51. doi: 10.1097/PTS.0000000000000084.

PMID:
24583954
36.

B-cell-targeted therapy in adult glomerulonephritis.

Tanna A, Tam FW, Pusey CD.

Expert Opin Biol Ther. 2013 Dec;13(12):1691-706. doi: 10.1517/14712598.2013.851191. Epub 2013 Nov 5. Review.

PMID:
24188581
37.

Antineutrophil cytoplasm antibody-positive pulmonary-renal syndrome in a patient with diffuse cutaneous systemic sclerosis.

Tonneijck L, Tanna A, Pusey CD.

BMJ Case Rep. 2013 Jun 13;2013. pii: bcr2012008099. doi: 10.1136/bcr-2012-008099.

38.

Author reply: To PMID 22137043.

Tanna AP, Budenz DL.

Ophthalmology. 2013 Apr;120(4):875-6. doi: 10.1016/j.ophtha.2012.11.020. No abstract available.

PMID:
23552088
39.

Correlation between intereye difference in visual field mean deviation values and relative afferent pupillary response as measured by an automated pupillometer in subjects with glaucoma.

Sarezky D, Krupin T, Cohen A, Stewart CW, Volpe NJ, Tanna AP.

J Glaucoma. 2014 Sep;23(7):419-23. doi: 10.1097/IJG.0b013e31827b1522.

PMID:
23337433
40.

Diagnosis of glaucoma and detection of glaucoma progression using spectral domain optical coherence tomography.

Grewal DS, Tanna AP.

Curr Opin Ophthalmol. 2013 Mar;24(2):150-61. doi: 10.1097/ICU.0b013e32835d9e27. Review.

PMID:
23328662
41.

Familial granulomatosis with polyangiitis: three cases of this rare disorder in one Indoasian family carrying an identical HLA DPB1 allele.

Tanna A, Salama AD, Brookes P, Pusey CD.

BMJ Case Rep. 2012 Nov 9;2012. pii: bcr0120125502. doi: 10.1136/bcr.01.2012.5502.

42.

Trends in self-reported visual impairment in the United States: 1984 to 2010.

Tanna AP, Kaye HS.

Ophthalmology. 2012 Oct;119(10):2028-32. doi: 10.1016/j.ophtha.2012.04.018. Epub 2012 Jun 8.

PMID:
22683061
43.

Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma.

Tanna AP, Budenz DL, Bandi J, Feuer WJ, Feldman RM, Herndon LW, Rhee DJ, Whiteside-de Vos J, Huang J, Anderson DR.

Ophthalmology. 2012 Mar;119(3):468-73. doi: 10.1016/j.ophtha.2011.08.041. Epub 2011 Dec 2.

44.

Thermal stability of bimatoprost, latanoprost, and travoprost under simulated daily use.

Johnson TV, Gupta PK, Vudathala DK, Blair IA, Tanna AP.

J Ocul Pharmacol Ther. 2011 Feb;27(1):51-9. doi: 10.1089/jop.2010.0115. Epub 2010 Nov 30.

45.
46.

Interobserver agreement and intraobserver reproducibility of the subjective determination of glaucomatous visual field progression.

Tanna AP, Bandi JR, Budenz DL, Feuer WJ, Feldman RM, Herndon LW, Rhee DJ, Whiteside-de Vos J.

Ophthalmology. 2011 Jan;118(1):60-5. doi: 10.1016/j.ophtha.2010.04.038. Epub 2010 Aug 17.

PMID:
20723992
47.

Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs.

Tanna AP, Rademaker AW, Stewart WC, Feldman RM.

Arch Ophthalmol. 2010 Jul;128(7):825-33. doi: 10.1001/archophthalmol.2010.131.

PMID:
20625041
48.

Optic disk excavation in nonarteritic anterior ischemic optic neuropathy.

Punjabi OS, Tanna AP, Rosenberg MA.

J Glaucoma. 2011 Feb;20(2):71-3. doi: 10.1097/IJG.0b013e3181dddf5c.

PMID:
20436358
49.

Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe.

Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, Creti R, Ekelund K, Koliou M, Tassios PT, van der Linden M, Straut M, Vuopio-Varkila J, Bouvet A, Efstratiou A, Schalén C, Henriques-Normark B; Strep-EURO Study Group, Jasir A.

J Clin Microbiol. 2009 Apr;47(4):1155-65. doi: 10.1128/JCM.02155-08. Epub 2009 Jan 21.

50.

Assessment of anti-inflammatory and hepatoprotective potency of Polyalthia longifolia var. pendula leaf in Wistar albino rats.

Tanna A, Nair R, Chanda S.

J Nat Med. 2009 Jan;63(1):80-5. doi: 10.1007/s11418-008-0288-2. Epub 2008 Sep 23.

PMID:
18810575

Supplemental Content

Support Center